Dr Wai Kei Jacky LAM
Department of Chemical Pathology
The Chinese University of Hong Kong
Dr Lam's research focus is on the biology of cell-free DNA (cfDNA) and the development of new cfDNA biomarkers for clinical applications. The discovery of the molecular characteristics of plasma Epstein-Barr virus DNA in nasopharyngeal carcinoma (NPC) has led to the development of novel diagnostic assays with clinical applications for screening and prognostication. In addition to assay development, he has also contributed to the establishment of the international recommendation on the use of EBV-based biomarkers for NPC screening.